164 related articles for article (PubMed ID: 7786518)
1. Renal, endocrine and vascular effects of atrial natriuretic peptide in a novel vasopressin-deficient genetically hypertensive strain of rat.
al-Barazanji KA; Balment RJ
Exp Physiol; 1995 Mar; 80(2):275-84. PubMed ID: 7786518
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral effects of the peptide ANF on renal function and blood pressure in hypertensive rats.
al-Barazanji K; Balment RJ
J Physiol; 1989 Nov; 418():261-71. PubMed ID: 2533609
[TBL] [Abstract][Full Text] [Related]
3. Plasma atrial natriuretic peptide in vasopressin deficiency: the effects of acute water deprivation in rats.
Burgess WJ; Balment RJ
J Endocrinol; 1992 Dec; 135(3):431-8. PubMed ID: 1487697
[TBL] [Abstract][Full Text] [Related]
4. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
5. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
6. The involvement of vasopressin in the renal actions of atrial natriuretic peptide in conscious fluid-balanced rats.
Burgess WJ; Balment RJ
J Endocrinol; 1993 Sep; 138(3):413-20. PubMed ID: 8277217
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide in plasma, atria, ventricles, and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats.
Ruskoaho H; Taskinen T; Pesonen A; Vuolteenaho O; Leppäluoto J; Tuomisto L
Endocrinology; 1989 May; 124(5):2595-603. PubMed ID: 2523304
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
Wang H; Wilson N; McNeill JR
Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
[TBL] [Abstract][Full Text] [Related]
9. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
Edwards BS; Schwab TR; Zimmerman RS; Heublein DM; Jiang NS; Burnett JC
Circ Res; 1986 Dec; 59(6):663-7. PubMed ID: 2949886
[TBL] [Abstract][Full Text] [Related]
11. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
12. Blunted renal responses to atrial natriuretic peptide and its reversal by unclipping in one-kidney, one clip Goldblatt hypertensive rats.
Huang WC; Wu JN
J Hypertens; 1997 Feb; 15(2):181-9. PubMed ID: 9469794
[TBL] [Abstract][Full Text] [Related]
13. The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs.
Golbaekdal K; Nielsen CB; Pedersen EB
J Pharm Pharmacol; 1996 Nov; 48(11):1174-9. PubMed ID: 8961168
[TBL] [Abstract][Full Text] [Related]
14. Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients.
Ferri C; Bellini C; Coassin S; Baldoncini R; Luparini RL; Perrone A; Santucci A
Circulation; 1994 Dec; 90(6):2859-69. PubMed ID: 7994831
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure and renal function in a novel vasopressin-deficient, genetically hypertensive rat strain.
Ashton N; Balment RJ
J Physiol; 1989 Mar; 410():21-34. PubMed ID: 2795478
[TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Selçuk Y; San A; Bakan E; Yiğitoğlu R
Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
[TBL] [Abstract][Full Text] [Related]
17. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
18. Pressor hormones regulate atrial-stretch-induced release of atrial natriuretic peptide in the pithed rat.
Ruskoaho H; Vakkuri O; Arjamaa O; Vuolteenaho O; Leppäluoto J
Circ Res; 1989 Mar; 64(3):482-92. PubMed ID: 2563674
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
20. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
Franco-Saenz R; Somani P; Mulrow PJ
Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
